These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Blood levels in relation to dosage of 3,4 dimethyl-5 sulfanilamido-isoxazole (gantrisin) in children with clinical observations. PRICE PC; HANSEN AE Tex Rep Biol Med; 1951; 9(4):764-79. PubMed ID: 14901327 [No Abstract] [Full Text] [Related]
37. [THERAPEUTIC ACTION OF 2-SULFANILAMIDO-5-METHOXYPYRIMIDINE ON SUBACUTE AND CHRONIC CHOLECYSTITIS]. VALENTI G; BELLODI G Policlinico Prat; 1964 Aug; 71():1273-7. PubMed ID: 14192188 [No Abstract] [Full Text] [Related]
38. [Influencing of the tubular function in renal excretion of 4-sulfanilamido-2, 6-dimethylpyrimidine]. PORTWICH F; BUTTNER H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(6):513-9. PubMed ID: 13407769 [No Abstract] [Full Text] [Related]
39. [PHARMACOKINETICS OF 2-SULFANILAMIDO-5-ETHYLPYRIMIDINE IN MAN]. PLANCHER AC; SALVI G; BACUZZI E Farmaco Prat; 1964 Nov; 19():550-9. PubMed ID: 14234089 [No Abstract] [Full Text] [Related]
40. [Sulfapyrimidine in chemotherapy; clinical experiences with 6-sulfanilamido-2,4-dimethylpyrimidin, L 30 of Nordmark and Co..]. HAUCH HJ; LUDWIG L; MULHENS K Z Gesamte Inn Med; 1950 Mar; 5(5-6):159-68. PubMed ID: 15425176 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]